drugset / Trial / NCT00979667

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

NCT00979667

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy of oseltamivir ,as compared with the placebo arm and zanamivir with its control arm with respect to symptoms duration among patients infected with influenza A (H1N1) virus.

Timeline

Start
2009-10
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 75 mg
Subject Zanamivir Small molecule 10 mg